Yayın:
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors – design, synthesis, biological evaluation and molecular modelling

dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorOSMANİYE, DERYA
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorÇavuşoğlu, Betül Kaya
dc.contributor.authorULVİYE, ACAR
dc.contributor.authorLEVENT, SERKAN
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0001-8270-4949
dc.contributor.orcid0000-0003-1879-1034
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0003-3692-163X
dc.contributor.orcid0000-0001-8815-153X
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2025-11-13T10:13:47Z
dc.date.issued2020-01-01
dc.identifier.doihttps://doi.org/10.1039/d0md00150c
dc.identifier.endpage1074
dc.identifier.issn2632-8682
dc.identifier.issue9
dc.identifier.openalexW3076299437
dc.identifier.startpage1063
dc.identifier.urihttps://hdl.handle.net/11421/3516
dc.identifier.urihttps://doi.org/10.1039/d0md00150c
dc.identifier.volume11
dc.language.isoen
dc.relation.ispartofRSC Medicinal Chemistry
dc.rightsopenAccess
dc.subjectMoclobemide
dc.subjectClorgyline
dc.subjectIC50
dc.subjectChemistry
dc.subjectMonoamine oxidase
dc.subjectLead compound
dc.subjectCombinatorial chemistry
dc.subjectStereochemistry
dc.subjectDrug
dc.subjectMonoamine oxidase B
dc.subjectMonoamine oxidase A
dc.subjectSelectivity
dc.subjectPharmacology
dc.subjectEnzyme
dc.subjectOrganic chemistry
dc.subjectBiochemistry
dc.subjectIn vitro
dc.subjectBiology
dc.subjectCatalysis
dc.titleNovel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors – design, synthesis, biological evaluation and molecular modelling
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5074136342
local.authorid.openalexA5017640266
local.authorid.openalexA5030511747
local.authorid.openalexA5033147884
local.authorid.openalexA5047270177
local.authorid.openalexA5075534569
local.authorid.openalexA5060247565

Dosyalar

Koleksiyonlar